PT935652E - Produtos de factor de crescimento de queratinocitos-2 - Google Patents
Produtos de factor de crescimento de queratinocitos-2Info
- Publication number
- PT935652E PT935652E PT97910119T PT97910119T PT935652E PT 935652 E PT935652 E PT 935652E PT 97910119 T PT97910119 T PT 97910119T PT 97910119 T PT97910119 T PT 97910119T PT 935652 E PT935652 E PT 935652E
- Authority
- PT
- Portugal
- Prior art keywords
- growth factor
- variants
- keratinocytes
- products
- chemical derivatives
- Prior art date
Links
- 239000003102 growth factor Substances 0.000 title 1
- 102000004864 Fibroblast growth factor 10 Human genes 0.000 abstract 2
- 108090001047 Fibroblast growth factor 10 Proteins 0.000 abstract 2
- 239000000126 substance Substances 0.000 abstract 2
- 230000008556 epithelial cell proliferation Effects 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/50—Fibroblast growth factor [FGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Pulmonology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2849396P | 1996-10-15 | 1996-10-15 | |
| US3278196P | 1996-12-06 | 1996-12-06 | |
| US3304696P | 1996-12-11 | 1996-12-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT935652E true PT935652E (pt) | 2004-07-30 |
Family
ID=27363281
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT97910119T PT935652E (pt) | 1996-10-15 | 1997-10-15 | Produtos de factor de crescimento de queratinocitos-2 |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP0935652B1 (pt) |
| JP (2) | JP2001506975A (pt) |
| AT (1) | ATE263239T1 (pt) |
| AU (1) | AU727678C (pt) |
| CA (1) | CA2269077C (pt) |
| DE (2) | DE69728415T2 (pt) |
| DK (1) | DK0935652T3 (pt) |
| ES (1) | ES2218666T3 (pt) |
| GB (1) | GB2322132B (pt) |
| HK (1) | HK1022714A1 (pt) |
| PT (1) | PT935652E (pt) |
| WO (1) | WO1998016642A1 (pt) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6693077B1 (en) | 1995-02-14 | 2004-02-17 | Human Genome Sciences, Inc. | Keratinocyte growth factor-2 |
| US6077692A (en) | 1995-02-14 | 2000-06-20 | Human Genome Sciences, Inc. | Keratinocyte growth factor-2 |
| US7232667B2 (en) | 1995-02-14 | 2007-06-19 | Human Genome Sciences, Inc. | Keratinocyte growth factor-2 polynucleotides |
| AU739773B2 (en) * | 1996-08-13 | 2001-10-18 | Human Genome Sciences, Inc. | Keratinocyte growth factor-2 (KGF-2 or fibroblast growth factor-12, FGF-12) |
| SI0941110T1 (en) * | 1996-10-15 | 2004-06-30 | Amgen Inc. | Uses of keratinocyte growth factor-2 |
| US6869927B1 (en) | 1997-12-22 | 2005-03-22 | Human Genome Sciences, Inc. | Keratinocyte growth factor-2 formulations |
| US6238888B1 (en) | 1997-12-22 | 2001-05-29 | Human Genone Sciences, Inc. | Keratinocyte growth factor-2 formulations |
| US6372494B1 (en) | 1999-05-14 | 2002-04-16 | Advanced Tissue Sciences, Inc. | Methods of making conditioned cell culture medium compositions |
| KR20020010920A (ko) * | 1999-06-02 | 2002-02-06 | 추후제출 | 각질세포 성장 인자-2 제제 |
| NZ516897A (en) * | 1999-07-02 | 2004-01-30 | Human Genome Sciences Inc | Polynucleotides and associated polypeptides for KGF-2 (also known as Fibroblast Growth Factor 12) to promote and accelerate internal and external wound healing |
| JP3966819B2 (ja) * | 2001-05-24 | 2007-08-29 | キム，スーギョン | 毛嚢に存在する新規の第２ケラチノサイト成長因子類似体 |
| EP1406573A4 (en) * | 2001-06-07 | 2005-03-30 | Skinmedica Inc | CONDITIONED CELL CULTURE MEDIA AND ITS USES |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2166278A1 (en) * | 1993-06-29 | 1995-01-12 | Denis J. Gospodarowicz | A truncated keratinocyte growth factor (kgf) having increased biological activity |
| EP0742830B1 (en) * | 1994-02-01 | 2001-07-18 | THE UNITED STATES OF AMERICA, as represented by the Secretary of the Department of Health and Human Services | Fusion proteins that include antibody and nonantibody portions |
| WO1996011949A2 (en) * | 1994-10-13 | 1996-04-25 | Amgen Inc. | Analogs of keratinocyte growth factor |
| ES2196088T3 (es) * | 1994-10-13 | 2003-12-16 | Amgen Inc | Analogos del factor de crecimiento de los queratinocitos. |
| EP0815115B1 (en) * | 1995-02-14 | 2003-05-28 | Human Genome Sciences, Inc. | Keratinocyte growth factor-2 |
| AU739773B2 (en) * | 1996-08-13 | 2001-10-18 | Human Genome Sciences, Inc. | Keratinocyte growth factor-2 (KGF-2 or fibroblast growth factor-12, FGF-12) |
-
1997
- 1997-10-15 CA CA002269077A patent/CA2269077C/en not_active Expired - Fee Related
- 1997-10-15 AU AU47576/97A patent/AU727678C/en not_active Ceased
- 1997-10-15 WO PCT/US1997/018607 patent/WO1998016642A1/en active IP Right Grant
- 1997-10-15 AT AT97910119T patent/ATE263239T1/de active
- 1997-10-15 DK DK97910119T patent/DK0935652T3/da active
- 1997-10-15 JP JP51856598A patent/JP2001506975A/ja active Pending
- 1997-10-15 GB GB9811279A patent/GB2322132B/en not_active Revoked
- 1997-10-15 DE DE69728415T patent/DE69728415T2/de not_active Expired - Lifetime
- 1997-10-15 ES ES97910119T patent/ES2218666T3/es not_active Expired - Lifetime
- 1997-10-15 EP EP97910119A patent/EP0935652B1/en not_active Expired - Lifetime
- 1997-10-15 PT PT97910119T patent/PT935652E/pt unknown
- 1997-10-15 DE DE19781038T patent/DE19781038T1/de not_active Withdrawn
-
2000
- 2000-02-17 HK HK00100939A patent/HK1022714A1/xx not_active IP Right Cessation
-
2008
- 2008-06-16 JP JP2008157291A patent/JP2008283980A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| DE19781038T1 (de) | 1998-12-10 |
| GB2322132A (en) | 1998-08-19 |
| JP2001506975A (ja) | 2001-05-29 |
| HK1022714A1 (en) | 2000-08-18 |
| DE69728415T2 (de) | 2004-08-12 |
| AU4757697A (en) | 1998-05-11 |
| CA2269077A1 (en) | 1998-04-23 |
| EP0935652B1 (en) | 2004-03-31 |
| WO1998016642A1 (en) | 1998-04-23 |
| DE69728415D1 (de) | 2004-05-06 |
| AU727678C (en) | 2005-05-12 |
| DK0935652T3 (da) | 2004-07-26 |
| JP2008283980A (ja) | 2008-11-27 |
| EP0935652A1 (en) | 1999-08-18 |
| CA2269077C (en) | 2004-04-06 |
| GB9811279D0 (en) | 1998-07-22 |
| ES2218666T3 (es) | 2004-11-16 |
| ATE263239T1 (de) | 2004-04-15 |
| AU727678B2 (en) | 2000-12-21 |
| GB2322132B (en) | 1999-09-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT101297A (pt) | Factores mitogenicos gliais, sua preparacao e utilizacao | |
| IL117425A0 (en) | Receptor activation by gas6 | |
| BG102071A (en) | Minor molecule inhibitors of rotamase enzymic activity | |
| WO1996034107A3 (en) | Antiviral proteins, dna coding sequences therefor, and uses thereof | |
| CY1107628T1 (el) | Ανθρωπινα ctla-4 αντισωματα και χρησεις αυτων | |
| ES2133813T3 (es) | Cadenas de lamininas: diagnostico y uso terapeutico. | |
| DE69942459D1 (de) | Isolierte nukleinsäuremoleküle die t-zellen induzierbare faktoren kodieren (tif), kodierte proteine und ihre anwendung | |
| PT935652E (pt) | Produtos de factor de crescimento de queratinocitos-2 | |
| IL143670A0 (en) | Methods for the expression of active protein-immunoglobulin fusions, active protein-immunoglobulin fusions obtained thereby and pharmaceutical compositions containing the same | |
| BR9916209A (pt) | Cadeia de receptor de citocina | |
| DE69726884D1 (de) | Menschliches sdf-5 protein und diesbezügliche zusammensetzungen | |
| AU6745287A (en) | Dna sequences coding for proteins having the biological activity of husi-type i inhibitors, biotechnological methods for the preparation of said proteins and pharmaceutical compositions containing said proteins | |
| DK1082423T3 (da) | Cyclin E2-gener og -proteiner | |
| ATE302002T1 (de) | Verwendung von pyrazolderivaten zur behandlung von unfruchtbarkeit | |
| WO1997008934A3 (en) | Aryl acrylic acid derivatives useful as protein tyrosine phosphatase inhibitors | |
| CA2239282A1 (en) | Fused isoindolones as inhibitors of protein kinase c | |
| DK0977859T3 (da) | Den neurotrofiske faktor NNT-1 | |
| DE69838615D1 (de) | ppGpp-SYNTHETASE UND EXPRESSIONSSYSTEME ZUR VERBESSERTEN HERSTELLUNG VON PROTEINEN | |
| ATE389014T1 (de) | Phosphorylierte glyoxalase i und deren verwendung | |
| DK143984A (da) | Nitrogenkilde til organismer | |
| AU4210900A (en) | Products and methods for treating ptp lar related diseases | |
| FR2654430B1 (fr) | Nouveaux derives de peptides, utilisables comme inhibiteurs des collagenases bacteriennes. | |
| MX9803354A (es) | Reactivo para el tratamiento de enfermedades o trastornos relacionado con niveles de receptor de crecimiento endotelial vascular y su uso. |